Dr Claire George, laboratory director at Concateno, a leading drug and alcohol testing company, said: "The positivity rate of 3.23% reported in this study demonstrates drug use in the workplace is ...
Inovio Pharmaceuticals has once again diluted its stock at far below market prices, killing its recent rally. INO's latest try at bringing a treatment to market is INO-3107, for which it expects ...
Concateno, one of Europe's leading drug and alcohol testing company, took over Oxfordshire-based Cozart earlier this year in a £64.5m deal. Concateno hopes to save £2m a year by shutting its ...